T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Phase 1
Recruiting
- Conditions
- Glioblastoma MultiformeAstrocytoma, Grade IV
- Interventions
- Biological: Allogeneic cytomegalovirus-specific T cells
- First Posted Date
- 2023-12-06
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Queensland Institute of Medical Research
- Target Recruit Count
- 58
- Registration Number
- NCT06157541
- Locations
- 🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺Newro Foundation, Bowen Hills, Queensland, Australia
🇦🇺Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas
Phase 1
Completed
- Conditions
- Lymphoma
- Interventions
- Biological: Autologous AdE1- Latent Membrane Protein CTLs
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Queensland Institute of Medical Research
- Target Recruit Count
- 8
- Registration Number
- NCT00779337
- Locations
- 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia
The Prevalence of Rheumatic Heart Disease in School Children in Fiji
- Conditions
- Rheumatic Heart Disease
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Queensland Institute of Medical Research
- Target Recruit Count
- 2000
- Registration Number
- NCT00779662
© Copyright 2025. All Rights Reserved by MedPath